Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giuseppina Rea
Observed names:
G. Rea,
Rea, Giuseppina
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0002-5420-395X
Observed ORCID:
0000-0002-5420-395X
OpenAlex ID:
A5086849700
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
2019
·
Crescenzo D’Alterio
, Maria Buoncervello
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
122
PDF
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
2020
·
Vincenzo Quagliariello
, Michelino De Laurentiis
, et al.
·
International Journal of Molecular Sciences
·
84
PDF
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
2022
·
Caterina Ieranò
, Dario Righelli
, et al.
·
Journal for ImmunoTherapy of Cancer
·
74
PDF
Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
2021
·
Alessandro Ottaiano
, Stefania Scala
, et al.
·
Therapeutic Advances in Medical Oncology
·
44
Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation
2019
·
Rosa Camerlingo
, Roberta Miceli
, et al.
·
PLoS ONE
·
41
PDF
Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease
2021
·
Maria A. Riemma
, Ida Cerqua
, et al.
·
British Journal of Pharmacology
·
40
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
2023
·
Sara Santagata
, Giuseppina Rea
, et al.
·
Hepatology International
·
30
PDF
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
2020
·
Crescenzo D’Alterio
, Antonella Zannetti
, et al.
·
Cancers
·
28
PDF
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
2019
·
Caterina Ieranò
, Crescenzo D’Alterio
, et al.
·
Cell Death and Disease
·
27
PDF
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018
·
Anna Maria Trotta
, Sara Santagata
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
24
PDF
Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences
2020
·
Stefano Tomassi
, Anna Maria Trotta
, et al.
·
Chemistry - A European Journal
·
23
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers
2018
·
Stefano Tomassi
, Caterina Ieranò
, et al.
·
Bioorganic & Medicinal Chemistry
·
19
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
2024
·
Sara Santagata
, Giuseppina Rea
, et al.
·
British Journal of Cancer
·
17
PDF
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study
2021
·
Alessandro Ottaiano
, Angela Petito
, et al.
·
Cancers
·
10
PDF
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
2024
·
Luigi Portella
, Giulia Bertolini
, et al.
·
Heliyon
·
9
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury
2022
·
Aniello Schiano Moriello
, Fiorentina Roviezzo
, et al.
·
Biomolecules
·
9
PDF
Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study
2020
·
Claudia von Arx
, Giuseppina Rea
, et al.
·
Cancers
·
9
PDF
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer
2024
·
Sara Santagata
, Anna Maria Trotta
, et al.
·
Clinical Cancer Research
·
7
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells
2024
·
Daniela Russo
, Anna Spina
, et al.
·
PLoS ONE
·
6
PDF
New cell block containing agarose for cytopathological diagnosis of tumor samples
2017
·
Roberta Miceli
, Giosuè Scognamiglio
, et al.
·
Diagnostic Cytopathology
·
5
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification
2024
·
Anna Maria Trotta
, Vincenzo Mazzarella
, et al.
·
European Journal of Medicinal Chemistry
·
3
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides
2022
·
Stefano Tomassi
, Caterina Ieranò
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Basal NK activity and early Treg function inhibition predicts Nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial
2019
·
S. Santagata
, A.M. Trotta
, et al.
·
Annals of Oncology
·
3
Abstract 6675: Basal NK activity and early Tregs inhibition predicts nivolumab responsiveness in metastatic renal cancer patients (REVOLUTION) trial
2020
·
Sara Santagata
, Anna Maria Trotta
, et al.
·
Cancer Research
·
2
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells
2026
·
Federica Auletta
, Caterina Ieranò
, et al.
·
Cell Death Discovery
·
1
PDF
Show more works
View as search
Works count:
57
Citation count:
647
H-index:
13
I10-index:
14
Year
Topic
Type